001     861200
005     20210130000735.0
024 7 _ |a 10.1097/MNM.0000000000000982
|2 doi
024 7 _ |a 0143-3636
|2 ISSN
024 7 _ |a 1473-5628
|2 ISSN
024 7 _ |a pmid:30875335
|2 pmid
024 7 _ |a WOS:000462182500012
|2 WOS
024 7 _ |a 2128/23415
|2 Handle
024 7 _ |a altmetric:57165465
|2 altmetric
037 _ _ |a FZJ-2019-01732
082 _ _ |a 610
100 1 _ |a Sommerauer, Michael
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Cis-4-[18F]fluoro-D-proline detects neurodegeneration in patients with akinetic-rigid parkinsonism
260 _ _ |a [s.l.]
|c 2019
|b Ovid
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1552657705_21968
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Objectives This study aimed to investigate whether the amino acid PET tracer cis-4-[18F]fluoro-D-proline [D-cis-[18F]FPro] shows increased uptake in the basal ganglia of patients with neurodegenerative akinetic-rigid parkinsonism. D-Cis-[18F]FPro is a sensitive PET tracer for inflammation-associated neurodegeneration in animal models. We hypothesized that D-cis-[18F]FPro might also be a sensitive marker of alterations of the basal ganglia in parkinsonian syndromes.Participants and methods Ten patients with neurodegenerative akinetic-rigid parkinsonism (five with idiopathic Parkinson’s disease and five with atypical parkinsonian syndromes) were imaged with D-cis-[18F]FPro and compared with 13 patients with brain tumors who had no basal ganglia involvement. PET images 20–50 min after injection were evaluated and tracer uptake in the basal ganglia was quantified using volume-of-interest analysis with basal ganglia to background ratios. The severity of disease was assessed with unified Parkinson’s disease rating scale III and correlated with D-cis-[18F]FPro uptake.Results In patients with parkinsonism, volume-of-interest analysis showed mild, but significantly increased D-cis-[18F]FPro uptake in the basal ganglia, pronounced in the lenticular nucleus. Disease severity correlated with D-cis-[18F]FPro uptake in the right pallidum (r=−0.687, P=0.041).Conclusion Data suggest that D-cis-[18F]FPro is a sensitive marker of inflammation-associated degenerative processes in parkinsonian syndromes.
536 _ _ |a 572 - (Dys-)function and Plasticity (POF3-572)
|0 G:(DE-HGF)POF3-572
|c POF3-572
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Galldiks, Norbert
|0 P:(DE-Juel1)143792
|b 1
|u fzj
700 1 _ |a Barbe, Michael T.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Stoffels, Gabriele
|0 P:(DE-Juel1)131627
|b 3
|u fzj
700 1 _ |a Willuweit, Antje
|0 P:(DE-Juel1)144347
|b 4
|u fzj
700 1 _ |a Coenen, Heinrich Hubert
|0 P:(DE-Juel1)131816
|b 5
|u fzj
700 1 _ |a Schroeter, Michael
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Timmermann, Lars
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 8
|u fzj
700 1 _ |a Langen, Karl-Josef
|0 P:(DE-Juel1)131777
|b 9
|u fzj
773 _ _ |a 10.1097/MNM.0000000000000982
|g p. 1 -
|0 PERI:(DE-600)2028880-3
|n 4
|p 383-387
|t Nuclear medicine communications
|v 40
|y 2019
|x 0143-3636
856 4 _ |y Published on 2019-04-30. Available in OpenAccess from 2020-04-30.
|u https://juser.fz-juelich.de/record/861200/files/Sommerauer_2019_Nuclear%20Medicine%20Communications_Cis-4-18Ffluoro-D-proline%20detects%20neurodegeneration%20in%20patients%20with%20akinetic-rigid%20parkinsonism.pdf
856 4 _ |y Published on 2019-04-30. Available in OpenAccess from 2020-04-30.
|x pdfa
|u https://juser.fz-juelich.de/record/861200/files/Sommerauer_2019_Nuclear%20Medicine%20Communications_Cis-4-18Ffluoro-D-proline%20detects%20neurodegeneration%20in%20patients%20with%20akinetic-rigid%20parkinsonism.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:861200
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)143792
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)131627
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)144347
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)131816
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)131720
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 9
|6 P:(DE-Juel1)131777
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|2 G:(DE-HGF)POF3-500
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NUCL MED COMMUN : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 1
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21